Pacific Biosciences Of California reported $1.14B in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 44.58M 1.85M
Agilent A:US $ 1428M 48M
Bruker BRKR:US $ 608.1M 88.7M
Danaher DHR:US $ 7322M 992M
Fluidigm FLDM:US $ 30.86M 18.88M
General Electric GE:US $ 22460M 9323M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Illumina ILMN:US $ 4196M 237M
Luminex LMNX:US $ 271.56M 37.85M
Myriad Genetics MYGN:US $ 118.4M 30.5M
Nanostring Technologies NSTG:US $ 160.38M 236.12M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Pacific Biosciences Of California PACB:US $ 1144.37M 211.98M
Perkinelmer PKI:US $ 572.81M 415.42M
Quidel QDEL:US $ 593.22M 387.83M
Thermo Fisher Scientific TMO:US $ 7023M 1440M
Waters WAT:US $ 663.62M 20.16M